KR101501889B1 - 저용량 라모세트론 함유 구강 내 붕괴정 - Google Patents

저용량 라모세트론 함유 구강 내 붕괴정 Download PDF

Info

Publication number
KR101501889B1
KR101501889B1 KR1020147010720A KR20147010720A KR101501889B1 KR 101501889 B1 KR101501889 B1 KR 101501889B1 KR 1020147010720 A KR1020147010720 A KR 1020147010720A KR 20147010720 A KR20147010720 A KR 20147010720A KR 101501889 B1 KR101501889 B1 KR 101501889B1
Authority
KR
South Korea
Prior art keywords
ramosetron
disintegrating tablet
hydrochloride
pharmaceutically acceptable
acid
Prior art date
Application number
KR1020147010720A
Other languages
English (en)
Korean (ko)
Other versions
KR20140081829A (ko
Inventor
히로유키 고지마
다케히코 야스지
테츠야 타무라
아츠시 간바야시
Original Assignee
아스텔라스세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스텔라스세이야쿠 가부시키가이샤 filed Critical 아스텔라스세이야쿠 가부시키가이샤
Publication of KR20140081829A publication Critical patent/KR20140081829A/ko
Application granted granted Critical
Publication of KR101501889B1 publication Critical patent/KR101501889B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020147010720A 2011-10-28 2012-10-26 저용량 라모세트론 함유 구강 내 붕괴정 KR101501889B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011237240 2011-10-28
JPJP-P-2011-237240 2011-10-28
PCT/JP2012/077687 WO2013062073A1 (ja) 2011-10-28 2012-10-26 低用量ラモセトロン含有口腔内崩壊錠

Publications (2)

Publication Number Publication Date
KR20140081829A KR20140081829A (ko) 2014-07-01
KR101501889B1 true KR101501889B1 (ko) 2015-03-12

Family

ID=48167898

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147010720A KR101501889B1 (ko) 2011-10-28 2012-10-26 저용량 라모세트론 함유 구강 내 붕괴정

Country Status (3)

Country Link
JP (1) JP5365949B2 (ja)
KR (1) KR101501889B1 (ja)
WO (1) WO2013062073A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5984320B2 (ja) * 2014-05-26 2016-09-06 大原薬品工業株式会社 ホリナートカルシウム含有フィルムコーティング錠
JP6768309B2 (ja) * 2015-04-28 2020-10-14 大原薬品工業株式会社 光安定性を向上したシロドシン含有着色錠剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
JP2005213244A (ja) * 2004-01-30 2005-08-11 Astellas Pharma Inc 下痢型過敏性腸症候群治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2002138055A (ja) * 2000-10-31 2002-05-14 Nipro Corp 口腔内速崩壊性圧縮成型物およびその製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
JP2005213244A (ja) * 2004-01-30 2005-08-11 Astellas Pharma Inc 下痢型過敏性腸症候群治療剤

Also Published As

Publication number Publication date
WO2013062073A1 (ja) 2013-05-02
JPWO2013062073A1 (ja) 2015-04-02
KR20140081829A (ko) 2014-07-01
JP5365949B2 (ja) 2013-12-11

Similar Documents

Publication Publication Date Title
JP6545839B2 (ja) 口腔内崩壊錠及びその製造方法
JP4707073B2 (ja) アトルバスタチン経口投与用粒子状医薬組成物
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP7096164B2 (ja) ジアミン誘導体を含む口腔内崩壊錠
KR20130030306A (ko) 약학 조성물
KR101479824B1 (ko) 용출 안정성 제제
JP5974469B2 (ja) 錠剤の製造方法
Parmar et al. Co-processing of small molecule excipients with polymers to improve functionality
JP5134802B2 (ja) 塩酸ブロムヘキシン含有量低下の防止方法
JP2013533881A (ja) バノキセリンを含有する医薬組成物
KR101501889B1 (ko) 저용량 라모세트론 함유 구강 내 붕괴정
JP5978335B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
TWI762450B (zh) 超高速崩解錠劑及其製造方法
JP2008127320A (ja) 口腔内速崩壊性固形製剤
WO2012042951A1 (ja) アトルバスタチン含有医薬錠剤
US8741344B1 (en) Dispersible tablet
JP7250305B2 (ja) メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
KR20140076998A (ko) 에스오메프라졸 유리염기 또는 그의 알칼리염을 포함하는 고미가 차폐된 약학 제제 및 이의 제조방법
WO2009128489A1 (ja) 塩酸バンコマイシンを含有する錠剤
WO2014171307A1 (ja) 小児への投与に適した速崩壊錠とその簡便な製造方法
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP4658306B2 (ja) 錠剤用医薬組成物
DK177906B1 (en) Dispersible tablet
WO2014171306A1 (ja) 小動物への投与に適した速崩壊錠とその簡便な製造方法
CN115803020A (zh) 含有苯磺酸米洛巴林的口腔崩解片剂

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180219

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20200218

Year of fee payment: 6